Disclaimer: This page may contain affiliate links. CoinMarketCap may be compensated if you visit any affiliate links and you take certain actions such as signing up and transacting with these affiliate platforms. Please refer to Affiliate Disclosure
Enzyme empowers you to build and scale investment strategies of your choice - from discretionary and robo to ETFs and market making. Security is our priority. Our second generation smart contract-enforced platform is thoroughly tested and audited before any mainnet deployments are made.
What is Enzyme?
Enzyme is a decentralized platform designed to revolutionize the way asset management operates in the digital and decentralized finance (DeFi) space. It leverages blockchain technology to offer users a comprehensive and secure system for managing a wide array of digital assets. At its core, Enzyme provides a platform where individuals can easily create, manage, and scale various investment strategies, ranging from discretionary and automated (robo) strategies to exchange-traded funds (ETFs) and market-making operations.
The platform is powered by its native token, MLN, which plays a crucial role in its ecosystem. The MLN token is utilized for various purposes within the Enzyme platform, including governance, protocol fees, and incentivizing certain behaviors that contribute to the ecosystem's health and growth.
One of the key features of Enzyme is its emphasis on security. Recognizing the critical importance of safeguarding users' assets, Enzyme has implemented a robust security framework. This includes the deployment of second-generation smart contracts, which are rigorously tested and audited before being launched on the mainnet. This meticulous approach to security ensures that the platform remains resilient against vulnerabilities and provides a trustworthy environment for asset management.
Enzyme's on-chain asset management system offers a unified application interface that simplifies access to digital assets and DeFi protocols. However, it's important to note that while Enzyme facilitates these interactions, it does not bear responsibility for the operation, functionality, or security of the underlying protocols. Consequently, users are encouraged to conduct their own research and exercise due diligence when engaging with these protocols, as the value of assets can fluctuate due to various factors inherent to the DeFi space.
How is Enzyme secured?
Enzyme prioritizes security to ensure the safety and integrity of its platform, which is designed to facilitate a wide range of investment strategies. The security framework of Enzyme is multifaceted, incorporating both proprietary measures and industry-standard practices to safeguard the platform and its users' assets.
Firstly, Enzyme grants users a single, non-exclusive, non-transferable, and limited license, emphasizing the platform's commitment to maintaining a secure and controlled environment. This approach underscores that while Enzyme provides the tools and infrastructure for investment strategies, it does not bear responsibility for the security of the underlying blockchain protocols. This distinction is crucial for users to understand their role and the scope of Enzyme's security measures.
To bolster security further, Enzyme employs industry-accepted security measures, which are continually updated and refined to address new and emerging threats. This proactive stance on security involves regular audits and the implementation of best practices to protect against the loss, misuse, and alteration of data. Such measures are essential in the dynamic and often volatile world of cryptocurrencies, where the landscape of threats evolves rapidly.
Moreover, Enzyme's platform is powered by the MLN token, which plays a central role in the ecosystem. The use of smart contracts is a cornerstone of Enzyme's security strategy. These contracts are rigorously tested and audited before deployment on the mainnet, ensuring that they function as intended and provide a secure foundation for users' investment activities. This smart contract-enforced platform represents the second generation of Enzyme's technology, reflecting the platform's ongoing commitment to security and innovation.
How will Enzyme be used?
Enzyme serves as a comprehensive platform designed for decentralized on-chain asset management, catering to a wide array of financial activities within the cryptocurrency space. It enables users to construct, manage, and scale diverse investment strategies, ranging from discretionary and automated (robo) strategies to exchange-traded funds (ETFs) and market making. This versatility is facilitated through its online application and associated services, providing a user-friendly interface for engaging with digital assets.
The platform is powered by its native token, which plays a crucial role in its ecosystem, facilitating various operations and transactions. Enzyme's commitment to security is evident through its rigorous testing and auditing processes, ensuring that its smart contract-enforced infrastructure is secure before being deployed on the mainnet.
By leveraging Enzyme, users can participate in decentralized finance (DeFi) activities, creating and executing investment strategies tailored to their preferences and risk tolerance. This opens up opportunities for both individual and institutional investors to explore new avenues for asset management in the cryptocurrency domain, without the need for intermediaries.
What key events have there been for Enzyme?
Enzyme, recognized for its innovative approach to on-chain asset management, has marked several significant milestones that have contributed to its growing prominence in the cryptocurrency and blockchain space. Central to its evolution has been the launch of its on-chain asset management system, a pivotal development that allows users to build, scale, and manage investment strategies directly on the blockchain. This system leverages the power of smart contracts to ensure security and efficiency, reflecting Enzyme's commitment to providing a secure platform for its users.
Further emphasizing its dedication to fostering innovation and growth within its ecosystem, Enzyme introduced a grant program. This initiative supports developers and strategists in creating new investment products and strategies, thereby enriching the platform's offerings and encouraging community participation.
In addition to these developments, Enzyme has continually refined its services and platform features to enhance user experience and meet the evolving needs of its community. This includes granting users a limited license to access and utilize the platform, ensuring that it remains a secure and reliable environment for managing digital assets.
Who are the founders of Enzyme?
Enzyme Finance, initially known as Melon, was co-founded by Mona El Isa and Rito Trinkler in 2016. Both founders brought a wealth of experience from the traditional financial sector to the cryptocurrency and blockchain space. Mona El Isa's background includes a tenure at Goldman Sachs, where she served as a vice president, showcasing her deep understanding of financial markets and investment strategies. Rito Trinkler, on the other hand, is a mathematician known for his expertise in applying innovative technologies to solve complex problems within the financial industry.
What is the target market of Enzyme?
Enzyme caters to a diverse audience within the financial ecosystem. This dual focus is designed to bridge the existing divide between conventional asset management practices and the burgeoning crypto market.
Given this comprehensive approach, Enzyme's target market includes:
Retail Investors: Individuals looking for a user-friendly platform to manage their crypto investments with a high degree of security and flexibility. These users benefit from the ability to experiment with various investment strategies without needing extensive technical knowledge.
Enterprise-Level Investors: Institutions and professional asset managers seeking to diversify their portfolios into cryptocurrencies and digital assets. Enzyme offers them a secure and scalable solution that aligns with traditional asset management practices while providing exposure to the innovative potential of the crypto market.
The live Enzyme price today is $15.65 USD with a 24-hour trading volume of $1,753,546 USD. We update our MLN to USD price in real-time. Enzyme is down 3.41% in the last 24 hours. The current CoinMarketCap ranking is #598, with a live market cap of $41,749,578 USD. It has a circulating supply of 2,667,594 MLN coins and a max. supply of 2,669,203 MLN coins.